The stock of Aclarion Inc (ACON) has seen a 0.11% increase in the past week, with a 5.56% gain in the past month, and a -34.34% decrease in the past quarter. The volatility ratio for the week is 9.56%, and the volatility levels for the past 30 days are at 10.31% for ACON. The simple moving average for the last 20 days is -1.91% for ACON’s stock, with a simple moving average of -59.06% for the last 200 days.
Is It Worth Investing in Aclarion Inc (NASDAQ: ACON) Right Now?
Moreover, the 36-month beta value for ACON is 0.46. Analysts have varying opinions on the stock, with 2 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for ACON is 9.53M and currently, short sellers hold a 3.16% of that float. On November 08, 2024, ACON’s average trading volume was 594.91K shares.
ACON) stock’s latest price update
The stock of Aclarion Inc (NASDAQ: ACON) has decreased by -5.97 when compared to last closing price of 0.20.Despite this, the company has seen a gain of 0.11% in its stock price over the last five trading days. globenewswire.com reported 2024-10-10 that Fireside Chat Scheduled for 2:00 PM ET on October 15, 2024 BROOMFIELD, Colo., Oct. 10, 2024 (GLOBE NEWSWIRE) — Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced today that Aclarion’s CEO, Brent Ness, has been invited to present at the 2024 Maxim Healthcare Virtual Summit, presented by Maxim Group LLC, on Tuesday, October 15th, 2024, at 2:00 p.m.
ACON Trading at 0.07% from the 50-Day Moving Average
After a stumble in the market that brought ACON to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -97.51% of loss for the given period.
Volatility was left at 10.31%, however, over the last 30 days, the volatility rate increased by 9.56%, as shares surge +0.71% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -19.45% lower at present.
During the last 5 trading sessions, ACON rose by +0.11%, which changed the moving average for the period of 200-days by -91.39% in comparison to the 20-day moving average, which settled at $0.1879. In addition, Aclarion Inc saw -94.24% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for ACON
Current profitability levels for the company are sitting at:
- -87.11 for the present operating margin
- -2.97 for the gross margin
The net margin for Aclarion Inc stands at -109.38. The total capital return value is set at -2.86. Equity return is now at value -714.18, with -231.70 for asset returns.
Based on Aclarion Inc (ACON), the company’s capital structure generated 0.32 points at debt to capital in total, while cash flow to debt ratio is standing at -6.75. The debt to equity ratio resting at 0.47. The interest coverage ratio of the stock is -4.59.
Currently, EBITDA for the company is -4.71 million with net debt to EBITDA at 0.1. When we switch over and look at the enterprise to sales, we see a ratio of 26.8. The receivables turnover for the company is 2.74for trailing twelve months and the total asset turnover is 0.02. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.23.
Conclusion
To wrap up, the performance of Aclarion Inc (ACON) has been mixed in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
